Absolute Antibody
Absolute Antibody is a rapidly growing global company specializing in recombinant antibody technology. We offer antibody sequencing, engineering and recombinant production as custom services, as well as a unique reagents catalog of engineered recombinant antibodies and Fc Fusion proteins.
Antibodies for Tumor Marker Antigens
Absolute Antibody offers a large catalog of 75+ tumor marker antigen antibodies, including anti-TAA (tumor associated antigens) and anti-TSA (tumor specific antigens). Absolute Antibody recombinant an...
Anti-Virus Antibodies
Absolute Antibody recombinant engineered antibodies empower virology researchers by providing tools that meet the demands of today’s scientific inquiries.
Neuroscience Research Antibodies
Absolute Antibody carries a variety of recombinant antibodies to aid in neuroscience research, with targets implicated in neurotransmission, neurodevelopment, neuropathology, substance abuse, and more...
Research Grade Biosimilars Antibodies
Absolute Antibody provides a range of research-grade biosimilar antibodies, including Trastuzumab, Gemtuzumab, Rituximab, Infliximab, Daclizumab, Basiliximab, Cetuximab, and Eculizumab. Each biosimila...
VivopureX™ Antibodies for In Vivo Research
VivopureX™ antibodies are recombinant mouse antibodies ideal for in vivo research in mouse models. The collection consists of popular antibody clones, many originally obtained from rats or hamsters, w...
Absolute Antibody is a rapidly growing global company specializing in recombinant antibody technology. We offer antibody sequencing, engineering and recombinant production as custom services, as well as a unique reagents catalog of engineered recombinant antibodies and Fc Fusion proteins.
Since our founding in 2012, we have been at the forefront of the movement to make recombinant antibodies more readily available to research labs. Our company mission is to make engineered recombinant antibodies accessible to all, with customers including leading pharmaceutical, biotechnology and diagnostics companies, as well as academic researchers in more than 60 countries worldwide.


